Pyxis Oncology Inc (PYXS) support and resistance · rev $2.8M
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
This page maps Pyxis Oncology Inc (PYXS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
PYXS currently screens at market cap $109.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PYXS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PYXS quote page for the session range and the stock page for the full model.
Not investment advice.